Icon

Cresemba - (372 mg/vial ; For Injection)

Isavuconazonium Sulfate Astellas
372 mg/vial ; For Injection
Less Than $1000 mn
None None
Less Than 5
None
None None
CRESEMBA ® is an azole antifungal indicated for use in the treatment of: • Invasive aspergillosis. • Invasive mucormycosis.
Yes
*** ***** - **** **, **** *** **** - *** **, ****
Cresemba Patent 1
******* *******
  1. *** *, **** : * **** ** ** ***** *** ***** *** *** ****.

Cresemba - (186 mg ; Capsule)

Isavuconazonium Sulfate Astellas
186 mg ; Capsule
Less Than $1000 mn
None None
More Than 5
None
None None
CRESEMBA ® is an azole antifungal indicated for use in the treatment of: • Invasive aspergillosis. • Invasive mucormycosis.
Yes
*** - *** **, ****. *** ***** - **** **, ****.
Cresemba Patent 1 Patent 2 Patent 3
******* *******
  1. *** *, **** : * **** ** ** ***** *** ***** *** **** ****.

Cresemba - (74.5 mg ; Capsule)

Isavuconazonium Sulfate Astellas
74.5 mg ; Capsule
Less Than $1000 mn
None None
More Than 5
None
None None
CRESEMBA ® is an azole antifungal indicated for use in the treatment of: • Invasive aspergillosis. • Invasive mucormycosis.
Yes
*** - *** **, ****. *** ***** - **** **, ****. **** ***** - **** **, ****.
Cresemba Patent 1 Patent 2 Patent 3
******* *******
  1. *** *, **** : * **** ** ** ***** *** ***** *** *** ****.

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.